Plant fully operational now, no material impact from 4-5 days closure AMRJ's 4QFY21 operating performance was in line with our estimates as strong revenue growth led operating leverage diluted the impact of higher RM cost. Weak demand visibility and lead price inflation will impact near term performance. Its strategy to meet the upcoming challenge from new chemistries would be an important driver for the stock. We have left our FY22E/FY23E EPS estimate largely unchanged. We...